Search - tctmd.com

Displaying 361 - 380 of 660

Sort: Relevancy | Date

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Daily News

Los SLF de 2ª Generación son la Mejor Opción para Pacientes víctimas de STEMI

December 09, 2013

Presentation

ST with Second-generation DES vs. BMS: Network Meta-analysis of Primary PCI Trials in STEMI

Presenter: 183206|Femi Philip

December 08, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Daily News

Un Antibiótico tras una PCI Primaria ayuda a Reducir el Remodealdo VI tras un cuadro de STEMI

Jason Kahn

November 01, 2013

News Daily News

STEMI患者接受直接冠状动脉介入治疗后使用抗生素可以帮助减少左室重构

Jason Kahn

November 01, 2013

News Daily News

Antibiotic After Primary PCI Helps Reduce LV Remodeling After STEMI

Jason Kahn

November 01, 2013

Presentation TCT 2013

DCB and BMS Interaction: A Critical Look at the Data

Presenter: Francesco Liistro

October 31, 2013

Presentation TCT 2013

Evidence-Based Medicine: Second-Generation DES Are Safer Than BMS and Should Be Used in All Patients During Primary PCI

Presenter: Tullio Palmerini

October 31, 2013

News Industry News

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

October 31, 2013

News Conference News TCT 2013

Drug-coated Balloons May Become Standard of Care in ISR

October 31, 2013

News Industry News

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

October 31, 2013

Presentation TCT 2013

US and EU Guideline Similarities and Differences: The Primary PCI Procedure (DES vs. BMS, Thrombus Aspiration, Radial vs. Femoral, and More)

Presenter: Stefan James

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Industry News

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

October 30, 2013

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

News Conference News TCT 2013

Paclitaxel-Coated Balloons Show Promise in Two Studies

October 29, 2013

Presentation TCT 2013

Stop the Debate! Selective Use of BMS Is Rational and Cost-Effective

Presenter: David Cohen

October 28, 2013

News Conference News TCT 2013

Cre8, BioFreedom Polymer-Free DES Show Promise

October 28, 2013

News Conference News TCT 2013

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

October 28, 2013

Advertisement

Second-Generation DES the Better Choice for STEMI Patients

Los SLF de 2ª Generación son la Mejor Opción para Pacientes víctimas de STEMI

ST with Second-generation DES vs. BMS: Network Meta-analysis of Primary PCI Trials in STEMI

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

Un Antibiótico tras una PCI Primaria ayuda a Reducir el Remodealdo VI tras un cuadro de STEMI

STEMI患者接受直接冠状动脉介入治疗后使用抗生素可以帮助减少左室重构

Antibiotic After Primary PCI Helps Reduce LV Remodeling After STEMI

DCB and BMS Interaction: A Critical Look at the Data

Evidence-Based Medicine: Second-Generation DES Are Safer Than BMS and Should Be Used in All Patients During Primary PCI

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

Drug-coated Balloons May Become Standard of Care in ISR

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

US and EU Guideline Similarities and Differences: The Primary PCI Procedure (DES vs. BMS, Thrombus Aspiration, Radial vs. Femoral, and More)

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

Paclitaxel-Coated Balloons Show Promise in Two Studies

Stop the Debate! Selective Use of BMS Is Rational and Cost-Effective

Cre8, BioFreedom Polymer-Free DES Show Promise

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content